## 3 Results
### Results of Synthesis
#### 3.4.1 Cornea Preservation Quantitative Parameters
\begin{table}
\begin{tabular}{l l l} \hline \hline
**Author Year** & **Viable Endothelial Cell Density (CCD) (cells/mm2)\({}^{\star}\) + Optisol-CS** & **Viable Endothelial Cell Density (ECD) (cells/mm2)\({}^{\star}\) + Distinct Media** \\ \hline [PERSON] and [PERSON], 2016 [22] & Optisol-GS & Cortisol \\ Day 1: 2868 + 318 & Day 1: 2731 + 3944 \(p=0.065\) \\ Day 2: 3664 + 352 & Day 3: 2832 + 3566 \(p=0.655\) \\ Day 2: 2599 + 334 & Day 27: 2475 \(\pm\) 377 \(p=0.177\) \\ Day 10: 2482 + 296 & Day 10: 2349 + 396 \(p=0.049\) \\ Day 14: 2417 + 384 & Day 14: 2256 \(\pm\) 336 \(p=0.110\) \\ \hline [PERSON] et al., 2016 [24] & Optisol-GS mean charge in ECD & Optisol-GS with amphoteric B \\
0-14 days, control: \(\alpha_{0.06}\) ug/mL: \(-\)191.5\(\_p\) = 073 & 0.06 \(p\)\(\pm\) 259.2 \(p=0.73\) \\
0.12 ing/mL: \(-\)208.6\(\_p\) = 0.01 & 0.12 ing/mL: 1142.5\(\_p\) = 0.01 \\
0.255\(\_-\) -46.75\(\_p\) = 0.45 & 0.255 \(\_-\)288.42\(\_p\) = 0.45 \\ \[PERSON] et al., 2021 [26] & Optisol-GS & Sinusel \\  & comparison of \(\sigma\) days: & comparison of 7 days: \\  & day 1: 2946 \(\pm\) 457 & day 1: 2829 \(\pm\) 423.9 \(p=0.135\) \\  & day 7: 2835 \(\pm\) 493, & day 7: 2723 \(\pm\) 419.9 \(p=0.18\) \\  & comparison of 14 days: & comparison of 14 days \\  & day 1: 2282 \(\pm\) 699 & day 1: 2804 \(\pm\) 423.9 \(p=0.782\) \\  & day 1: 2880 \(\pm\) 383 & day 14: 245 \(\pm\) 589. \(p=0.851\) \\ \[PERSON] et al., 2015 [27] & Optisol-GS & Eusol-C \\  & baseline (3151 \(\pm\) 612); \(p=0.319\) & baseline (2925 \(\pm\) 431); \(p=0.319\) \\
1 w (3058 \(\pm\) 481); \(p=0.319\) & 1 w (3099 \(\pm\) 474.0 \(p=0.319\) \\ \[PERSON] et al., 2014 [28] & Optisol-GS & Optisol-GS with amphoteric B or voriconazole \\  & Day to Day 27 & Day to Day 27 \\  & Voriconazole \(\phi\)\(\times\) MC: \(-\)72.8 (233.7\(\_p\) = 0.6 & Voriconazole \(\phi\)\(\times\) MC: \(-\)43 (60.3); \(p=0.6\) \\  & Ampidentic B 0.25 \(\times\) MC: \(-\)50.9 (467.5\(\_p\) = 0.74 & Ampidentic B 0.25 \(\times\) MC: \(-\)567.3 (058.4\(\_p\) = 0.74 \\  & Ampidentic B 0.5 \(\times\) MC: \(-\)107.6 (044.4); \(p=0.27\) & Ampidentic B 0.5 \(\times\) MC: \(-\)109.2 (436.9); \(p=0.27\) \\  & Ampidentic B 11 \(\times\) MC: \(-\)184.0 (404.2); \(p=0.07\) \\  & Ampidentic B 10 \(\times\) MC: \(-\)99.9 (41.8\(\_p\) = 0.04 & Ampidentic B 10 \(\times\) MC: indeterminate \\  & Dys to Day 14 & Day to Day 14 \\  & Voriconazole \(\phi\)\(\times\) MC: \(-\)182.3 (1150.0); \(p=0.41\) & Voriconazole \(\phi\)\(\times\) MC: \(-\)289.2 (10.1); \(p=0.41\) \\  & Ampidentic B 0.25 \(\times\) MC: \(-\)102.3 (370.3); \(p=0.38\) & Ampidentic B 0.25 \(\times\) MC: \(-\)291.8 (204.4); \(p=0.38\) \\  & Ampidentic B 0.5 \(\times\) MC: \(-\)567.9 (063.2); \(p=0.50\) & Ampidentic B 0.5 \(\times\) MC: \(-\)362.7 (202.8); \(p=0.50\) \\  & Ampidentic B 11 \(\times\) MC: \(-\)363.6 (708.9); \(p=0.45\) & Ampidentic B 11 \(\times\) MC: \(-\)473.1 (288.4); \(p=0.45\) \\  & Ampidentic B 10 \(\times\) MC: \(-\)206.3 (233.9); \(p=0.16\) & Ampidentic B 10 \(\times\) MC: indeterminate \\ \hline \hline \end{tabular}
\end{table} 
Table 7: Extracted results for endothelial cell density—CCD. \begin{table}
\begin{tabular}{l l l} \hline